TL;DR

Eight NHS hospitals have begun a twelve-month evaluation of surgical AI, first reported by Digital Health. The aim is squarely operational: treat more people using the theatres and staff already in place. Proximie’s Intelligence Suite will run across 104 theatres, endoscopy suites and catheterisation laboratories, covering upwards of 20,000 procedures.

What is being measured

The trusts have not been named. Proximie will say only that six sit in London and two elsewhere in England.

The target is the dead time between cases. Data from the system will be used to find where delays accumulate between one procedure and the next, and to schedule available theatre time more tightly. Nothing here is about clinical decision-making — it is a capacity play, aimed at wringing more activity out of infrastructure that already exists rather than building or hiring.

The more interesting design choice is the shared assessment framework applied at all eight sites. That makes results comparable rather than eight separate anecdotes, and it is what would let anyone judge whether gains hold up in different hospitals or depend on local conditions. Across the year each site will record what the software’s prompts do to how many patients get through and how smoothly lists run, with the conclusions intended to steer adoption elsewhere.

Worth watching for

Theatre productivity schemes have a long history in the NHS and a mixed record, typically because savings measured during a pilot fail to persist once attention moves elsewhere. A twelve-month window is long enough to expose that, if anyone reports the tail honestly.

The number to interrogate when results land is the counterfactual: how much of any improvement came from the software, and how much from eight trusts paying close attention to their scheduling for a year.

Looking forward

This is the third distinct NHS AI story in a single morning, and the most concrete. The MHRA’s independent commission has recommended staged authorisation and lifelong monitoring, and the same regulator opened a live testing sandbox in Manchester.

Read together, they describe a health service that has stopped debating whether to deploy AI and started building the machinery to find out whether it works. This trial is that question asked at scale, with a comparison framework attached — which is more than most NHS technology pilots have ever carried.